About
Contact
Subscribe
e-Edition

Make Home Page

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter

- Site search

Home
News
Sports
- Local Sports
- National Sports
Business
Opinion
A & E
Life
Features & Magazines
Classifieds
Weather
Obituaries
Parcel Pickup

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

AN2 Therapeutics, Inc. - Common Stock (NQ:ANTX)

1.105 +0.035 (+3.27%)

Streaming Delayed Price Updated: 12:13 PM EST, Jan 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about AN2 Therapeutics, Inc. - Common Stock

< Previous 1 2 Next >

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

September 23, 2025

Via Benzinga

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

May 01, 2025

Via Benzinga

Why Levi Strauss Shares Are Trading Lower By Over 10%; Here Are 20 Stocks Moving Premarket ↗

October 03, 2024

Via Benzinga

Citizens And 2 Other Penny Stocks Insiders Are Buying ↗

August 15, 2024

Via Benzinga

Why Is AN2 Therapeutics (ANTX) Stock Down 35% Today? ↗

August 09, 2024

AN2 Therapeutics stock is down on Friday after ANTX investors learned of the company terminating its EBO-301 Phase 2/3 clinical trial.

Via InvestorPlace

ANTX Stock Earnings: AN2 Therapeutics Beats EPS for Q2 2024 ↗

August 13, 2024

ANTX stock results show that AN2 Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.

Via InvestorPlace

Crude Oil Rises; Blend Labs Shares Jump Following Q2 Results ↗

August 09, 2024

Via Benzinga

US Stocks Edge Lower; EchoStar Shares Tumble After Q2 Results ↗

August 09, 2024

Via Benzinga

Lung Disease Focused AN2 Therapeutics' Lackluster Data Prompts To Stop Phase 3 Study Of Lung Infection Candidate, Halves Workforce ↗

August 09, 2024

AN2 Therapeutics reported topline results from the Phase 2/3 EBO-301 study of epetraborole in treatment-refractory MAC lung disease. The study showed similar sputum culture conversion rates between...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

August 09, 2024

We have all of the biggest pre-market stock movers that traders need to know about on Friday with the latest news breakdowns!

Via InvestorPlace

12 Health Care Stocks Moving In Friday's After-Market Session ↗

June 14, 2024

Via Benzinga

ANTX Stock Earnings: AN2 Therapeutics Beats EPS for Q1 2024 ↗

May 14, 2024

ANTX stock results show that AN2 Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

April 04, 2024

Via Benzinga

ANTX Stock Earnings: AN2 Therapeutics Beats EPS for Q4 2023 ↗

March 28, 2024

ANTX stock results show that AN2 Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.

Via InvestorPlace

ZoomInfo Technologies To Rally Around 50%? Here Are 10 Top Analyst Forecasts For Tuesday ↗

February 13, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Nasdaq Edges Lower; ContextLogic Shares Surge ↗

February 12, 2024

U.S. stocks traded mostly higher toward the end of trading, while the Nasdaq Composite moved slightly lower on Monday. The Dow traded up 0.52% to 38,873.28 while the NASDAQ fell 0.10% to 15,975.16. The...

Via Benzinga

Topics Stocks

Why Big Lots Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

February 12, 2024

Shares of Big Lots, Inc. (NYSE: BIG) fell sharply during Monday’s session after the company reported preliminary fourth-quarter results. Also, Loop Capital downgraded the stock from Hold to Sell and...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

February 12, 2024

Via Benzinga

Dow Surges Over 150 Points; Gilead Sciences To Acquire CymaBay Therapeutics For $4.3B ↗

February 12, 2024

U.S. stocks traded higher midway through trading, with the Dow Jones index jumping over 150 points on Monday. The Dow traded up 0.48% to 38,856.99 while the NASDAQ rose 0.26% to 16,031.87. The S&P 500...

Via Benzinga

Topics Stocks

US Stocks Mixed; Trimble Issues Weak Outlook ↗

February 12, 2024

U.S. stocks traded mixed this morning, with the Dow Jones index falling around 20 points on Monday. Following the market opening Monday, the Dow traded down 0.05% to 38,651.80 while the NASDAQ rose...

Via Benzinga

Topics Stocks

Why Is Infectious Disease-Focused AN2 Therapeutics Stock Sinking Today? ↗

February 12, 2024

AN2 Therapeutics pauses Phase 3 enrollment for epetraborole trial in Mycobacterium Avium Complex lung disease. Updates expected in summer 2024.

Via Benzinga

Monday.com Reports Q4 Results, Joins AN2 TherapeuticsAnd Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

February 12, 2024

U.S. stock futures were mixed this morning, with the Dow futures trading lower by around 45 points on Monday. Shares of monday.com Ltd. (NASDAQ: MNDY) fell sharply in today’s pre-market trading after...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

February 12, 2024

Via Benzinga

Top 5 Health Care Stocks That May Fall Off A Cliff ↗

September 06, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

$16M Bet On This Biotechnology Stock? Check Out These 3 Stocks Insiders Are Buying ↗

August 23, 2023

Although U.S. stocks closed mostly lower on Tuesday, there were a few notable insider trades.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

August 17, 2023

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

May 16, 2023

Via Benzinga

Top 5 Health Care Stocks That May Dip ↗

January 27, 2023

The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies.

Via Benzinga

Lennar To Rally Around 14%? Plus Keybanc Predicts $5,120 For This Stock ↗

November 14, 2022

Keybanc boosted the price target on Lennar Corporation (NYSE: LEN) from $89 to $100. Lennar shares fell 0.4% to close at $88.03 on Friday.

Via Benzinga

Uber, Lyft, AZZ And Other Big Losers From Tuesday ↗

October 12, 2022

U.S. stocks closed mixed with the Nasdaq Composite dropping more than 100 points on Tuesday. Here is the list of some big stocks recording losses in the previous session.

Via Benzinga

< Previous 1 2 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Opinion
Photo Galleries
Videos
Local Events
Classifieds
Obituaries

Services

About
Contact
Personnel
Advertise
Subscription Services
Promote Your Event
Dealer Locations
Email Alerts
Submission Forms

Contact Information

chroniclejournal.com
75 S. Cumberland Street
Thunder Bay, ON P7B 1A3
Phone: 807 343 6200
Email: circulation@chroniclejournal.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

AN2 Therapeutics, Inc. - Common Stock (NQ:ANTX)

Headline News about AN2 Therapeutics, Inc. - Common Stock

Sections

Services

Contact Information

Follow Us